Vivo Ventures VII, LLC

Vivo Ventures VII, LLC discloses dealings in 5 companies, chiefly Aclaris Therapeutics, Inc., Lite Strategy, Inc. and Codexis, Inc. Over a trading history stretching from 16 May 2013 to 30 August 2018, the count stands at 46 filings.

On the open market, the record shows 8 purchases worth €10.8M and 31 sales worth €41.4M. Netting one side against the other leaves €30.6M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2018, the count stands at 2 purchases and no sales.

A typical purchase (the median) is worth €111k. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +36.3%. These figures describe past trades and do not predict future prices.

Most recently, on 31 August 2018, the filings show an open-market purchase worth €2.8M in Airxpanders Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.